Telehealth Weight Loss Program for Obesity
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new telehealth-based weight loss program to determine the best first-line treatment for older adults with obesity and multiple chronic health issues. Participants will follow different treatment paths: some will focus on behavior changes (Behavioral Weight Loss Intervention), while others will follow prescribed diet and exercise plans (Prescriptive Weight Loss Intervention). The goal is to identify which combination of strategies most effectively aids weight loss and improves overall health. Suitable candidates have a BMI of 30 or higher, at least two ongoing health conditions, and live independently. As an unphased trial, this study provides a unique opportunity to explore innovative weight loss strategies tailored to individual health needs.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently using anti-obesity medications or certain bone-acting medications. It's best to discuss your specific medications with the trial team.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that weight loss programs focusing on behavior changes are generally safe and can lead to significant weight loss. Studies have found that these programs help people lose weight over several months without major safety issues, using techniques like problem-solving and self-control.
Similarly, personalized weight loss plans, which include specific diet and exercise routines, are considered safe. Guided by trained professionals, these plans have proven as effective as in-person programs for weight loss.
Both behavior-focused and personalized methods have been used safely in various settings, making them promising options for weight loss without significant side effects.12345Why are researchers excited about this trial?
Researchers are excited about the Telehealth Weight Loss Program for Obesity because it uniquely combines behavioral and prescriptive strategies in a flexible, telemedicine format. Unlike traditional in-person programs, this approach allows participants to receive personalized guidance from health coaches and licensed professionals directly at home, making it more accessible and convenient. The program also offers a dynamic method of adjusting strategies based on individual responses, which means if someone isn't seeing results, they can seamlessly switch to a more suitable intervention. This tailored and adaptable model could potentially increase success rates by focusing on individual needs and using real-time feedback and support.
What evidence suggests that this trial's treatments could be effective for obesity?
Research has shown that programs focused on changing behavior can aid in weight loss. For instance, one study found that 38.2% of people who received remote support lost at least 5% of their starting weight. In this trial, participants may receive a Behavioral Weight Loss Intervention, which includes health coaching and evidence-based behavior change techniques. Another study demonstrated that these programs also improved eating habits, such as reducing eating when not hungry.
Similarly, personalized plans with specific diet and exercise advice have shown positive results. In this trial, participants may receive a Prescriptive Weight Loss Intervention, involving tailored diet and exercise prescriptions. One study found that people following a personalized plan lost more weight than those who did not. Both methods, behavioral and personalized, are supported by evidence that they can aid in weight loss and are being tested in this trial.36789Who Is on the Research Team?
John A Batsis, MD
Principal Investigator
University of North Carolina, Chapel Hill
Are You a Good Fit for This Trial?
This trial is for English-speaking adults aged 65-85 with obesity (BMI ≥30) and at least two chronic conditions as defined by Medicare. Participants must be able to consent, have a stable weight in the past 12 weeks, and get medical clearance from their doctor. Those with recent COVID-19, dementia, bariatric surgery history, or certain severe health issues cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Treatment
Participants receive either a prescriptive or behavioral weight loss intervention
Adaptive Treatment
Non-responders are re-randomized to a different intervention strategy
Follow-up
Participants are monitored for weight maintenance and health outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Behavioural
- Prescriptive
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
National Institute on Aging (NIA)
Collaborator